Downregulation of BCL2 by miRNAs augments druginduced apoptosis - A combined computational and experimental approach

Journal of Cell Science

Volumn 125, Issue 6, 2012, Pages 1568-1578

  Singh, Richa ^a   Saini, Neeru ^a  

^a CSIR INSTITUTE OF GENOMICS AND INTEGRATIVE BIOLOGY   (India)

Author keywords

Apoptosis; BCL2; Etoposide; MicroRNA

Indexed keywords

CYTOCHROME C; MICRORNA; MICRORNA 195; MICRORNA 24 2; MICRORNA 365 2; PROTEIN BCL 2; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; BREAST CANCER; CANCER CELL; COMPUTATIONAL FLUID DYNAMICS; CONTROLLED STUDY; CYTOSOL; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; MITOCHONDRIAL MEMBRANE POTENTIAL; MITOCHONDRION; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN SECRETION;

APOPTOSIS; BREAST NEOPLASMS; CELL LINE, TUMOR; COMPUTATIONAL BIOLOGY; DOWN-REGULATION; FEMALE; GENETIC THERAPY; HEK293 CELLS; HUMANS; MICRORNAS; PROTO-ONCOGENE PROTEINS C-BCL-2;

EID: 84861220123     PISSN: 00219533     EISSN: 14779137     Source Type: Journal    
DOI: 10.1242/jcs.095976     Document Type: Article

References (64)

1. Ambros, V. (2004). The functions of animal microRNAs. Nature 431, 350-355.
2. Andersen, M. H., Svane, I. M., Kvistborg, P., Nielsen, O. J., Balslev, E., Reker, S., Becker, J. C. and Straten, P. T. (2005). Immunogenicity of Bcl-2 in patients with cancer. Blood 105, 728-734.
3. Baldwin, E. L. and Osheroff, N. (2005). Etoposide, topoisomerase II and cancer. Curr. Med. Chem. Anticancer Agents 5, 363-372.
4. Bartel, D. P. (2004). MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116, 281-297.
5. Bartel, D. P. (2009). MicroRNAs: target recognition and regulatory functions. Cell 136, 215-233.
6. Bentwich, I., Avniel, A., Karov, Y., Aharonov, R., Gilad, S., Barad, O., Barzilai, A., Einat, P., Einav, U., Meiri, E. et al. (2005). Identification of hundreds of conserved and nonconserved human microRNAs. Nat. Genet. 37, 766-770.
7. Blower, P. E. et al. (2007). MicroRNA expression profiles for the NCI-60 cancer cell panel. Mol. Cancer Ther. 6, 1483-1491.
8. Brennecke, J., Hipfner, D. R., Stark, A., Russell, R. B. and Cohen, S. M. (2003). bantam encodes a developmentally regulated microRNA that controls cell proliferation and regulates the proapoptotic gene hid in Drosophila. Cell 113, 25-36.
9. Budihardjo, I., Oliver, H., Lutter, M., Luo, X. and Wang, X. (1999). Biochemical pathways of caspase activation during apoptosis. Annu. Rev. Cell Dev. Biol. 15, 269-290.
10. Calin, G. A., Sevignani, C., Dumitru, C. D., Hyslop, T., Noch, E., Yendamuri, S., Shimizu, M., Rattan, S., Bullrich, F., Negrini, M. et al. (2004). Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc. Natl. Acad. Sci. USA 101, 2999-3004.
11. Cheadle, C., Vawter, M. P., Freed, W. J. and Becker, K. G. (2003). Analysis of microarray data using Z score transformation. J. Mol. Diagn. 5, 73-81.
12. Cheng, A. M., Byrom, M. W., Shelton, J. and Ford, L. P. (2005). Antisense inhibition of human miRNAs and indications for an involvement of miRNA in cell growth and apoptosis. Nucleic Acids Res. 33, 1290-1297.
13. Chipuk, J. E., Moldoveanu, T., Llambi, F., Parsons, M. J. and Green, D. R. (2010). The BCL-2 family reunion. Mol. Cell 37, 299-310.
14. Cimmino, A., Calin, G. A., Fabbri, M., Iorio, M. V., Ferracin, M., Shimizu, M., Wojcik, S. E., Aqeilan, R. I., Zupo, S., Dono, M. et al. (2005). miR-15 and miR-16 induce apoptosis by targeting BCL2. Proc. Natl. Acad. Sci. USA 102, 13944-13949.
15. Cory, S. and Adams, J. M. (2002). The Bcl2 family: regulators of the cellular life-ordeath switch. Nat. Rev. Cancer 2, 647-656.
16. Danial, N. N. and Korsmeyer, S. J. (2004). Cell death: critical control points. Cell 116, 205-219.
17. Desagher, S. and Martinou, J. C. (2000). Mitochondria as the central control point of apoptosis. Trends Cell Biol. 10, 369-377.
18. Dlugosz, P. J., Billen, L. P., Annis, M. G., Zhu, W., Zhang, Z., Lin, J., Leber, B. and Andrews, D. W. (2006). Bcl-2 changes conformation to inhibit Bax oligomerization. EMBO J. 25, 2287-2296.
19. Garzon, R., Calin, G. A. and Croce, C. M. (2009). MicroRNAs in Cancer. Annu. Rev. Med. 60, 167-179.
20. Goel, A., Prasad, A. K., Parmar, V. S., Ghosh, B. and Saini, N. (2007). 7,8-Dihydroxy-4-methylcoumarin induces apoptosis of human lung adenocarcinoma cells by ROS-independent mitochondrial pathway through partial inhibition of ERK/MAPK signaling. FEBS Lett. 581, 2447-2454.
21. Green, D. R. and Reed, J. C. (1998). Mitochondria and apoptosis. Science 281, 1309-1312.
22. Hamano, R., Miyata, H., Yamasaki, M., Kurokawa, Y., Hara, J., Moon, J. H., Nakajima, K., Takiguchi, S., Fujiwara, Y., Mori, M. et al. (2011). Overexpression of miR-200c induces chemoresistance in esophageal cancers mediated through activation of the Akt signaling pathway. Clin. Cancer Res. 17, 3029-3038.
23. Huang, J. C., Babak, T., Corson, T. W., Chua, G., Khan, S., Gallie, B. L., Hughes, T. R., Blencowe, B. J., Frey, B. J. and Morris, Q. D. (2007). Using expression profiling data to identify human microRNA targets. Nat. Methods 4, 1045-1049.
24. Iqbal, J., Neppalli, V. T., Wright, G., Dave, B. J., Horsman, D. E., Rosenwald, A., Lynch, J., Hans, C. P., Weisenburger, D. D., Greiner, T. C. et al. (2006). BCL2 expression is a prognostic marker for the activated B-cell-like type of diffuse large Bcell lymphoma. J. Clin. Oncol. 24, 961-968.
25. Kausch, I., Jiang, H., Thode, B., Doehn, C., Kruger, S. and Jocham, D. (2005). Inhibition of bcl-2 enhances the efficacy of chemotherapy in renal cell carcinoma. Eur. Urol. 47, 703-709.
26. Kloosterman, W. P. and Plasterk, R. H. (2006). The diverse functions of microRNAs in animal development and disease. Dev. Cell 11, 441-450.
27. Kojima, K., Fujita, Y., Nozawa, Y., Deguchi, T. and Ito, M. (2010). MiR-34a attenuates paclitaxel-resistance of hormone-refractory prostate cancer PC3 cells through direct and indirect mechanisms. Prostate 70, 1501-1512.
28. Lal, A., Navarro, F., Maher, C. A., Maliszewski, L. E., Yan, N., O'Day, E., Chowdhury, D., Dykxhoorn, D. M., Tsai, P., Hofmann, O. et al. (2009). miR-24 Inhibits cell proliferation by targeting E2F2, MYC, and other cell-cycle genes via binding to "seedless" 3'UTR microRNA recognition elements. Mol. Cell 35, 610-625.
29. Lim, L. P., Lau, N. C., Garrett-Engele, P., Grimson, A., Schelter, J. M., Castle, J., Bartel, D. P., Linsley, P. S. and Johnson, J. M. (2005). Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs. Nature 433,769-773.
30. Macfarlane, L. A. and Murphy, P. R. (2010). MicroRNA: biogenesis, function and role in cancer. Curr. Genomics 11, 537-561.
31. Majid, A., Tsoulakis, O., Walewska, R., Gesk, S., Siebert, R., Kennedy, D. B. and Dyer, M. J. (2008). BCL2 expression in chronic lymphocytic leukemia: lack of association with the BCL2 938A>C promoter single nucleotide polymorphism. Blood 111, 874-877.
32. Mayr, C., Hemann, M. T. and Bartel, D. P. (2007). Disrupting the pairing between let-7 and Hmga2 enhances oncogenic transformation. Science 315, 1576-1579.
33. Oltersdorf, T., Elmore, S. W., Shoemaker, A. R., Armstrong, R. C., Augeri, D. J., Belli, B. A., Bruncko, M., Deckwerth, T. L., Dinges, J., Hajduk, P. J. et al. (2005). An inhibitor of Bcl-2 family proteins induces regression of solid tumours. Nature 435, 677-681.
34. Ory, B., Ramsey, M. R., Wilson, C., Vadysirisack, D. D., Forster, N., Rocco, J. W., Rothenberg, S. M. and Ellisen, L. W. (2011). A microRNA-dependent program controls p53-independent survival and chemosensitivity in human and murine squamous cell carcinoma. J. Clin. Invest. 121, 809-820.
35. Papetti, M. and Augenlicht, L. H. (2011). Mybl2, downregulated during colon epithelial cell maturation, is suppressed by miR-365. Am. J. Physiol. Gastrointest. Liver Physiol. 3, G508-G518.
36. Pfaffl, M. W. (2001). A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 29, e45.
37. Pommier, Y., Sordet, O., Antony, S., Hayward, R. L. and Kohn, K. W. (2004). Apoptosis defects and chemotherapy resistance: molecular interaction maps and networks. Oncogene 23, 2934-2949.
38. Qian, L., Van Laake, L. W., Huang, Y., Liu, S., Wendland, M. F. and Srivastava, D. (2011). miR-24 inhibits apoptosis and represses Bim in mouse cardiomyocytes. J. Exp. Med. 208, 549-560.
39. Qin, B., Xiao, B., Liang, D., Xia, J., Li, Y. and Yang, H. (2011). MicroRNAs expression in ox-LDL treated HUVECs: MiR-365 modulates apoptosis and Bcl-2 expression. Biochem. Biophys. Res. Commun. 410, 127-133.
40. Qin, W., Shi, Y., Zhao, B., Yao, C., Jin, L., Ma, J. and Jin, Y. (2010). miR-24 regulates apoptosis by targeting the open reading frame (ORF) region of FAF1 in cancer cells. PLoS. ONE. 5, e9429.
41. Ranade, A. R., Cherba, D., Sridhar, S., Richardson, P., Webb, C., Paripati, A., Bowles, B. and Weiss, G. J. (2010). MicroRNA 92a-2*: a biomarker predictive for chemoresistance and prognostic for survival in patients with small cell lung cancer. J. Thorac. Oncol. 5, 1273-1278.
42. Reed, J. C. (2006). Drug insight: cancer therapy strategies based on restoration of endogenous cell death mechanisms. Nat. Clin. Pract. Oncol. 3, 388-398.
43. Reinhart, B. J., Slack, F. J., Basson, M., Pasquinelli, A. E., Bettinger, J. C., Rougvie, A. E., Horvitz, H. R. and Ruvkun, G. (2000). The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans. Nature 403, 901-906.
44. Skirnisdottir, I., Seidal, T., Gerdin, E. and Sorbe, B. (2002). The prognostic importance of p53, bcl-2, and bax in early stage epithelial ovarian carcinoma treated with adjuvant chemotherapy. Int. J. Gynecol. Cancer 12, 265-276.
45. Srivastava, N., Manvati, S., Srivastava, A., Pal, R., Kalaiarasan, P., Chattopadhyay, S., Gochhait, S., Dua, R. and Bamezai, R. N. (2011). miR-24-2 controls H2AFX expression regardless of gene copy number alteration and induces apoptosis by targeting antiapoptotic gene BCL-2: a potential for therapeutic intervention. Breast Cancer Res. 13, R39.
46. Strasser, A., Harris, A. W., Bath, M. L. and Cory, S. (1990). Novel primitive lymphoid tumours induced in transgenic mice by cooperation between myc and bcl-2. Nature 348, 331-333.
47. Su, Y. T., Chang, H. L., Shyue, S. K. and Hsu, S. L. (2005). Emodin induces apoptosis in human lung adenocarcinoma cells through a reactive oxygen species-dependent mitochondrial signaling pathway. Biochem. Pharmacol. 70, 229-241.
48. Ujifuku, K., Mitsutake, N., Takakura, S., Matsuse, M., Saenko, V., Suzuki, K., Hayashi, K., Matsuo, T., Kamada, K., Nagata, I. et al. (2010). miR-195, miR-455-3p and miR-10a(*) are implicated in acquired temozolomide resistance in glioblastoma multiforme cells. Cancer Lett. 296, 241-248.
49. Vecchione, A. and Croce, C. M. (2010). Apoptomirs: small molecules have gained the license to kill. Endocr. Relat. Cancer 17, F37-F50.
50. Volinia, S., Calin, G. A., Liu, C. G., Ambs, S., Cimmino, A., Petrocca, F., Visone, R., Iorio, M., Roldo, C., Ferracin, M. et al. (2006). A microRNA expression signature of human solid tumors defines cancer gene targets. Proc. Natl. Acad. Sci. USA 103, 2257-2261.
51. Wang, Q., Huang, Z., Xue, H., Jin, C., Ju, X. L., Han, J. D. and Chen, Y. G. (2008). MicroRNA miR-24 inhibits erythropoiesis by targeting activin type I receptor ALK4. Blood 111, 588-595.
52. Wang, X., Wang, J., Ma, H., Zhang, J. and Zhou, X. (2011). Downregulation of miR-195 correlates with lymph node metastasis and poor prognosis in colorectal cancer. Med. Oncol. [Epub ahead of print].
53. Xia, L., Zhang, D., Du, R., Pan, Y., Zhao, L., Sun, S., Hong, L., Liu, J. and Fan, D. (2008). miR-15b and miR-16 modulate multidrug resistance by targeting BCL2 in human gastric cancer cells. Int. J. Cancer 123, 372-379.
54. Xu, T., Zhu, Y., Xiong, Y., Ge, Y. Y., Yun, J. P. and Zhuang, S. M. (2009). MicroRNA-195 suppresses tumorigenicity and regulates G1/S transition of human hepatocellular carcinoma cells. Hepatology 50, 113-121.
55. Xu, Z., Xiao, S. B., Xu, P., Xie, Q., Cao, L., Wang, D., Luo, R., Zhong, Y., Chen, H. C. and Fang, L. R. (2011). miR-365, a novel negative regulator of interleukin-6 gene expression, is cooperatively regulated by Sp1 and NF-kappaB. J. Biol. Chem. 286, 21401-21412.
56. Yamamoto, K., Ichijo, H. and Korsmeyer, S. J. (1999). BCL-2 is phosphorylated and inactivated by an ASK1/Jun N-terminal protein kinase pathway normally activated at G(2)/M. Mol. Cell. Biol. 19, 8469-8478.
57. Yanai, S., Nakamura, S., Takeshita, M., Fujita, K., Hirahashi, M., Kawasaki, K., Kurahara, K., Sakai, Y. and Matsumoto, T. (2010). Translocation t(14;18)/IGHBCL2 in gastrointestinal follicular lymphoma: correlation with clinicopathologic features in 48 patients. Cancer 117, 2467-2477.
58. Yang, J., Liu, X., Bhalla, K., Kim, C. N., Ibrado, A. M., Cai, J., Peng, T. I., Jones, D. P. and Wang, X. (1997). Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked. Science 275, 1129-1132.
59. Youle, R. J. and Strasser, A. (2008). The BCL-2 protein family: opposing activities that mediate cell death. Nat. Rev. Mol. Cell Biol. 9, 47-59.
60. Zamore, P. D. and Haley, B. (2005). Ribo-gnome: the big world of small RNAs. Science 309, 1519-1524.
61. Zamzami, N., Susin, S. A., Marchetti, P., Hirsch, T., Gomez-Monterrey, I., Castedo, M. and Kroemer, G. (1996). Mitochondrial control of nuclear apoptosis. J. Exp. Med. 183, 1533-1544.
62. Zhang, J., Du, Y., Wu, C., Ren, X., Ti, X., Shi, J., Zhao, F. and Yin, H. (2010). Curcumin promotes apoptosis in human lung adenocarcinoma cells through miR-186* signaling pathway. Oncol. Rep. 24, 1217-1223.
63. Zhu, W., Shan, X., Wang, T., Shu, Y. and Liu, P. (2010). miR-181b modulates multidrug resistance by targeting BCL2 in human cancer cell lines. Int. J. Cancer 127, 2520-2529.
64. Zhu, H., Yang, Y., Wang, Y., Li, J., Schiller, P. W. and Peng, T. (2011). MicroRNA-195 promotes palmitate-induced apoptosis in cardiomyocytes by down-regulating Sirt1. Cardiovasc. Res. 92, 75-84.